
Revised Self-Monitoring Scale
Author(s) -
Gianina Toller,
Kamalini G. Ranasinghe,
Yann Cobigo,
Adam M. Staffaroni,
Brian S. Appleby,
Danielle Brushaber,
Giovanni Coppola,
Bradford C. Dickerson,
Kimiko DomotoReilly,
Julie A. Fields,
Jamie Fong,
Leah K. Forsberg,
Nupur Ghoshal,
Neill R. GraffRadford,
Murray Grossman,
Hilary W. Heuer,
Ging-Yuek Robin Hsiung,
Edward D. Huey,
David J. Irwin,
Kejal Kantarci,
Daniel Kaufer,
Diana Kerwin,
David S. Knopman,
John Kornak,
Joel H. Kramer,
Irene Litvan,
Ian R. Mackenzie,
Mario F. Mendez,
Bruce L. Miller,
Rosa Rademakers,
Eliana Marisa Ramos,
Katya Rascovsky,
Erik D. Roberson,
Jeremy Syrjanen,
Carmela Tartaglia,
Sandra Weıntraub,
Brad F. Boeve,
Adam L. Boxer,
Howard J. Rosen,
Katherine P. Rankin
Publication year - 2020
Publication title -
neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.91
H-Index - 364
eISSN - 1526-632X
pISSN - 0028-3878
DOI - 10.1212/wnl.0000000000009451
Subject(s) - asymptomatic , socioemotional selectivity theory , medicine , atrophy , frontotemporal dementia , psychology , gastroenterology , dementia , disease , gerontology
To investigate whether the Revised Self-Monitoring Scale (RSMS), an informant measure of socioemotional sensitivity, is a potential clinical endpoint for treatment trials for patients with behavioral variant frontotemporal dementia (bvFTD).